Annovis Bio, Inc. (ANVS)

USD 4.71

(-7.83%)

Gross Profit Summary of Annovis Bio, Inc.

  • Annovis Bio, Inc.'s latest annual gross profit in 2023 was - USD , down 0.0% from previous year.
  • Annovis Bio, Inc.'s latest quarterly gross profit in 2024 Q1 was - USD , down 0.0% from previous quarter.
  • Annovis Bio, Inc. reported a annual gross profit of - USD in annual gross profit 2022, down 0.0% from previous year.
  • Annovis Bio, Inc. reported a annual gross profit of - USD in annual gross profit 2021, down 0.0% from previous year.
  • Annovis Bio, Inc. reported a quarterly gross profit of - USD for 2024 Q1, down 0.0% from previous quarter.
  • Annovis Bio, Inc. reported a quarterly gross profit of - USD for 2023 Q2, down 0.0% from previous quarter.

Annual Gross Profit Chart of Annovis Bio, Inc. (2023 - 2017)

Historical Annual Gross Profit of Annovis Bio, Inc. (2023 - 2017)

Year Gross Profit Gross Profit Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%

Peer Gross Profit Comparison of Annovis Bio, Inc.

Name Gross Profit Gross Profit Difference
ADC Therapeutics SA 67.02 Million USD 100.0%
Alto Neuroscience, Inc. -373 Thousand USD 100.0%
Biohaven Pharmaceutical Holding Company Ltd. -3.36 Million USD 100.0%
Ginkgo Bioworks Holdings, Inc. 197.45 Million USD 100.0%
Nuvation Bio Inc. -222 Thousand USD 100.0%
Nuvation Bio Inc. -222 Thousand USD 100.0%
Arcus Biosciences, Inc. -223 Million USD 100.0%
Theriva Biologics, Inc. -135 Thousand USD 100.0%
Zymeworks Inc. -66.97 Million USD 100.0%